Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed ...
The Shield MCD test will be available to eligible Manulife customers beginning April 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results